North America Compounding Pharmacies Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Oral Medications, Topical Medications, Suppositories, and Others) and Therapeutic Area (Pain Medications, Hormone Replacement Therapies, Dermatological Applications, and Others)

No. of Pages: 77    |    Report Code: TIPRE00024688    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Compounding Pharmacies Market

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          North America Compounding Pharmacies Market – By Product

1.3.2          North America Compounding Pharmacies Market – By Therapeutic Area

1.3.3          North America Compounding Pharmacies Market– By Country

2.           North America Compounding Pharmacies Market– Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           North America Compounding Pharmacies Market– Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          North America PEST Analysis

4.3          Expert Opinion

5.           North America Compounding Pharmacies Market – Key Market Dynamics

5.1          Market Drivers

5.1.1          Drug Shortage Crisis

5.1.2          Benefits of Compounded Medications

5.1.3          Increasing Adoption of Customized Medicine (Personalized Medicine)

5.2          Market Restraints

5.2.1          Product Recalls and Stringent Regulatory Requirements

5.3          Market Opportunities

5.3.1          Growing Demand for Compounding Pharmacy During COVID-19

5.4          Future Trends

5.4.1          Growing Outsourcing Facilities for Manufacturing and Sales of Products

5.5          Impact Analysis

6.           Compounding Pharmacies Market– North America Analysis

6.1          North America Compounding Pharmacies Market Revenue Forecast and Analysis

7.           North America Compounding Pharmacies Market Analysis – By Product

7.1          Overview

7.2          North America Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

7.3          Oral Medications

7.3.1          Overview

7.3.2          Oral Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Topical Medications

7.4.1          Overview

7.4.2          Topical Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Suppositories

7.5.1          Overview

7.5.2          Suppositories: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Others

7.6.1          Overview

7.6.2          Others: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Compounding Pharmacies Market – By Therapeutic Area

8.1          Overview

8.2          Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

8.3          Pain Medications

8.3.1          Overview

8.3.2          Pain Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Hormone Replacement Therapies

8.4.1          Overview

8.4.2          Hormone Replacement Therapies: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Dermatological Applications

8.5.1          Overview

8.5.2          Dermatological Applications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Compounding Pharmacies Market Revenue and Forecasts to 2028 – Country Analysis

9.1          North America Compounding Pharmacies Market Revenue and Forecasts to 2028

9.1.1          North America Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.2          North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

9.1.3          US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.4          US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.4.1             US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.4.2             US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.5          Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.5.1             Canada Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.5.2             Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.5.3             Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

9.1.6          Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.6.1             Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.6.2             Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

9.1.6.3             Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

10.        Impact Of COVID-19 Pandemic on North America Compounding Pharmacies Market

10.1        North America: Impact Assessment of COVID-19 Pandemic

11.        North America Compounding Pharmacies Market– Industry Landscape

11.1        Overview

11.2        Organic Developments

11.2.1        Overview

11.3        Inorganic Developments

11.3.1        Overview

12.        Company Profiles

12.1        Fagron, Inc.

12.1.1        Key Facts

12.1.2        Business Description

12.1.3        Products and Services

12.1.4        Financial Overview

12.1.5        SWOT Analysis

12.1.6        Key Developments

12.2        Triangle Compounding Pharmacy

12.2.1        Key Facts

12.2.2        Business Description

12.2.3        Products and Services

12.2.4        Financial Overview

12.2.5        SWOT Analysis

12.2.6        Key Developments

12.3        B.Braun Melsungen AG

12.3.1        Key Facts

12.3.2        Business Description

12.3.3        Products and Services

12.3.4        Financial Overview

12.3.5        SWOT Analysis

12.3.6        Key Developments

12.4        PharMEDium Healthcare Holdings, Inc.

12.4.1        Key Facts

12.4.2        Business Description

12.4.3        Products and Services

12.4.4        Financial Overview

12.4.5        SWOT Analysis

12.4.6        Key Developments

12.5        Fresenius Kabi AG

12.5.1        Key Facts

12.5.2        Business Description

12.5.3        Products and Services

12.5.4        Financial Overview

12.5.5        SWOT Analysis

12.5.6        Key Developments

12.6        Avella specialty pharmacy

12.6.1        Key Facts

12.6.2        Business Description

12.6.3        Products and Services

12.6.4        Financial Overview

12.6.5        SWOT Analysis

12.6.6        Key Developments

12.7        Vertisis Custom Pharmacy

12.7.1        Key Facts

12.7.2        Business Description

12.7.3        Products and Services

12.7.4        Financial Overview

12.7.5        SWOT Analysis

12.7.6        Key Developments

12.8        US Compounding Inc.

12.8.1        Key Facts

12.8.2        Business Description

12.8.3        Products and Services

12.8.4        Financial Overview

12.8.5        SWOT Analysis

12.8.6        Key Developments

13.        Appendix

13.1        About the Insight Partners

13.2        Glossary of Terms

LIST OF TABLES

Table 1.              North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ million)

Table 2.              US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3.              US Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 4.              Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 5.              Canada Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 6.              Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 7.              Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Mn)

Table 8.              Organic Developments Done By Companies

Table 9.              Inorganic Developments Done By Companies

Table 10.            Glossary of Terms, Compounding Pharmacies Market

LIST OF FIGURES

Figure 1.            North America Compounding Pharmacies Market Segmentation

Figure 2.            North America Compounding Pharmacies Segmentation, By Country

Figure 3.            North America Compounding Pharmacies Market Overview

Figure 4.            Oral Medications Held Largest Share of Product Segment in North America Compounding Pharmacies Market

Figure 5.            US to Show Remarkable Growth During Forecast Period

Figure 6.            North America: PEST Analysis

Figure 7.            North America Compounding Pharmacies Market Impact Analysis of Drivers and Restraints

Figure 8.            North America Compounding Pharmacies Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.            North America Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

Figure 10.          Oral Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Topical Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Suppositories: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Others: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

Figure 15.          Pain Medications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Hormone Replacement Therapies: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Dermatological Applications: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Others: North America Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          North America Compounding Pharmacies Market Revenue Overview, By Country, 2020 (US$ Mn)

Figure 20.          North America Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

Figure 21.          US Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.          Canada Compounding Pharmacies Market Revenue And Forecasts to 2028 (US$ Mn)

Figure 23.          Mexico Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.          Impact of COVID-19 Pandemic in North American Country Markets

 

 

The List of Companies - North America Compounding Pharmacies Market

  1. Avella specialty pharmacy
  2. B.Braun Melsungen AG
  3. Fagron, Inc
  4. Fresenius Kabi AG
  5. PharMEDium Healthcare Holdings, Inc
  6. Triangle Compounding Pharmacy
  7. US Compounding Inc
  8. Vertisis Custom Pharmacy